Secondary Carcinoma — Trials

Secondary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

222 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: Guangzhou Medical University
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02659241	Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	active not recruiting	Early Phase 1	38	M.D. Anderson Cancer CenterOTHER	1	Apr 15, 2026	clinicaltrials

Data updated 22 days agoSource updated Apr 15, 2026source: clinicaltrials